"We would need to test approximately 300 people for HLA-B*58:01 to prevent 1 case of allopurinol SJS/TEN/[allopurinol hypersensitivity syndrome].... [I]t makes sense that excluding a genetically ...

Compared with non-users, allopurinol use ≥300 mg/day was correlated with a lower risk for developing chronic kidney disease stage ≥3 (hazard ratio, 0.87; 95 percent confidence interval ...

They were randomized to receive 100 mg to 300 mg of allopurinol per day or placebo. Primary outcome was the change in eGFR through 104 weeks. At enrollment, mean eGFR of the study population was ...

Certain textbooks/references suggest a maximum dose of allopurinol (Xyloprim, Lopurin) in patients with renal insufficiency. Presumably, this is because of renal excretion of the metabolite ...

“The most common dose, overwhelmingly, is the physician gives the patient 300 milligrams of allopurinol and never monitors how effective that is, whether they need more or whether they need les ...

Subjects received 100–300 mg/day of allopurinol plus standard therapy (n = 26), or standard therapy alone (n = 26). Standard therapy included antihypertensives and lipid-lowering drugs.

Improvement observed in estimated glomerular filtration rate in kidney transplant recipients treated with allopurinol for elevated uric acid. Urate-lowering treatment with allopurinol may help ...

Indoco Remedies Ltd has informed BSE that the Company has received the approval from United States Food & Drug Administration (USFDA) to manufacture and market Allopurinol 100 mg & 300 mg tablets ...

The company has received approval from the United States Food and Drug Administration (USFDA) to market generic Allopurinol tablets in the strengths of 100 mg and 300 mg, Unichem Laboratories said ...